Legato Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Legato Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$453K	Buy	+5,478	New	+$439K	0.04%	518
2026 Q1	–	Sell	-8,370	Closed	-$661K	–	738
2025 Q4	$661K	Sell	8,370 -6,910	-45%	-$598K	0.06%	471
2025 Q3	$1.4M	Sell	15,280 -2,770	-15%	-$226K	0.15%	209
2025 Q2	$1.18M	Hold	18,050	–	–	0.14%	232
2025 Q1	$1.21M	Buy	18,050 +12,010	+199%	+$717K	0.16%	200
2024 Q4	$334K	Buy	+6,040	New	+$347K	0.04%	487
2024 Q3	–	Sell	-7,440	Closed	-$474K	–	564
2024 Q2	$474K	Buy	7,440 +2,870	+63%	+$186K	0.06%	452
2024 Q1	$316K	Buy	+4,570	New	+$276K	0.04%	502

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Legato Capital Management's ANIP Position: Q2 2026 in Review

Legato Capital Management opened a new position in ANI Pharmaceuticals (ANIP) in Q2 2026: 5,478 shares worth $453K. The stake represents 0.04% of the portfolio and ranks #518 among its holdings. This is a return to the name: Legato Capital Management previously reported a position in ANIP as recently as Q4 2025.

Legato Capital Management first reported a position in ANIP in Q1 2024 and has held it in 8 quarters since. The position peaked at $1.4M in Q3 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

Legato Capital Management held 5,478 shares of ANI Pharmaceuticals worth $453K as of Q2 2026.
ANI Pharmaceuticals was a new Legato Capital Management position in Q2 2026.
ANI Pharmaceuticals made up 0.04% of Legato Capital Management's portfolio in Q2 2026, its #518 holding.
Legato Capital Management first reported a position in ANI Pharmaceuticals in Q1 2024 and has held it in 8 quarters since.
Legato Capital Management's ANI Pharmaceuticals position peaked at $1.4M in Q3 2025.
307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.